🔎 Trials Near Me

Home › Diabetic Eye Problems › Texas

Diabetic Eye Problems clinical trials in Texas

5 studies for Diabetic Eye Problems are looking for participants at sites in Texas.

Cities in Texas

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  • Austin Research Center for Retina ( Site 0033), Austin
  • Austin Retina Associates ( Site 0008), Austin
  • Retina Consultants of Texas ( Site 0001), Bellaire
  • and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705555

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

  • Texas Retina ( Site 0051), Arlington
  • Texas Retina Associates ( Site 0055), Fort Worth
  • Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100), Katy
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705607

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

  • Medical Center Ophthalmology Associates, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07588100

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

  • Austin Research Center for Retina /ID# 276101, Austin
  • Retina and Vitreous of Texas /ID# 283051, Bellaire
  • Star Retina /ID# 276513, Burleson
  • and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07592273

A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema

  • Site 111, Abilene
  • Site 129, Austin
  • Site 130, Houston
  • and 4 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07812090

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.